Ozempic and Rybelsus are medications that have become increasingly popular for managing type 2 diabetes and, more recently, for off-label use in weight loss. Both drugs contain semaglutide, a compound that mimics a hormone that is involved in the regulation of blood sugar and control of appetite. These drugs do work for many patients, but they are not without risk. With their use increasing, concern has grown over potential side effects. As more patients turn to these medications, it's essential to weigh the benefits against the risks. Understanding how each drug affects the body can help make safer choices. That’s why an Ozempic vs Rybelsus safety comparison is key for anyone considering these treatments.

1.   Gastrointestinal Issues

One of the most common side effects patients report experiencing with Ozempic and Rybelsus is gastrointestinal discomfort. Patients often report nausea, vomiting, diarrhea, and abdominal pain, especially when treatment is initiated or the dose is adjusted. These symptoms can be mild and last a few weeks. Such discomfort is sometimes severe enough to result in dehydration or discontinuation of therapy. This can exacerbate symptoms in individuals who already have other pre-existing digestive problems.